Method of treating melanoma

Details for Australian Patent Application No. 2008236994 (hide)

Owner Myriad Pharmaceuticals, Inc.

Inventors Laughlin, Mark

Agent Peter Maxwell & Associates

Pub. Number AU-A-2008236994

PCT Pub. Number WO2008/124823

Priority 60/910,967 10.04.07 US

Filing date 10 April 2008

Wipo publication date 16 October 2008

International Classifications

C07D 239/72 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/124823 Priority application(s): WO2008/124823

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008236995-Dosages and methods for the treatment of cancer

2008236993-Method of treating brain cancer